Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block
Primary Purpose
Spinal Cord Injuries
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Femoral nerve block with phenol
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Cord Injuries focused on measuring nerve block
Eligibility Criteria
Inclusion Criteria:
- Traumatic etiology
- Duration of spinal cord injury more than twelve months
- Spasticity of hip flexor and/or knee extensor muscle
- Use of any oral medications to reduce spasticity at stable doses for at least one month before first assessment
- The patients have to accept to continue same dose until end of the last assessment
- Medical clearance to participate
Exclusion Criteria:
- Having established contracture of the knee/hip joint
- Aged over 65 years
- History of surgery for knee/hip disorders
- Non-traumatic etiology
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
femoral nerve block
Arm Description
Outcomes
Primary Outcome Measures
Modified Ashworth Scale
Scale measures muscle tone (spasticity). (min-max:0-4).Higher values represent a worse outcome.
Secondary Outcome Measures
Functional independence measure
Scale measures level of independence on activities of daily life (min-max: 0-126) points).Motor subscale of FIM measure is used in this study (min-max:0-91). Higher values represent a better outcome.
Full Information
NCT ID
NCT03468439
First Posted
February 27, 2018
Last Updated
March 11, 2018
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03468439
Brief Title
Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block
Official Title
Short Term Effect of Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block With Phenol on Outcomes in People With Traumatic Spinal Cord Injury
Study Type
Interventional
2. Study Status
Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
January 2014 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
A pre-post descriptive study was performed to examine the immediate effects of ultrasound (US) guided femoral nerve block with phenol (UGFNBwP) in managing lower limb spasticity of individuals with traumatic spinal cord injury (SCI).
Detailed Description
Study Design: A pre-post descriptive study was performed. Objectives: To examine the immediate effects of ultrasound (US) guided femoral nerve block with phenol (UGFNBwP) in managing lower limb spasticity of individuals with traumatic spinal cord injury (SCI).
Setting: Ankara, Turkey Methods: Nineteen patients with traumatic SCI presenting with lower extremity spasticity were treated with UGFNBwP. Modified Ashworth Scale (MAS) of hip flexion and knee extension, functional independence measure (FIM) motor subscale, difficulty of catheterization (DoC), hygiene score (HS), spasm frequency (SF), sleep quality (SQ) and patient satisfaction (PS) were measured in all patients prior to treatment, at first week and second month.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
Keywords
nerve block
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
femoral nerve block
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
Femoral nerve block with phenol
Primary Outcome Measure Information:
Title
Modified Ashworth Scale
Description
Scale measures muscle tone (spasticity). (min-max:0-4).Higher values represent a worse outcome.
Time Frame
up to 8 weeks
Secondary Outcome Measure Information:
Title
Functional independence measure
Description
Scale measures level of independence on activities of daily life (min-max: 0-126) points).Motor subscale of FIM measure is used in this study (min-max:0-91). Higher values represent a better outcome.
Time Frame
up to 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Traumatic etiology
Duration of spinal cord injury more than twelve months
Spasticity of hip flexor and/or knee extensor muscle
Use of any oral medications to reduce spasticity at stable doses for at least one month before first assessment
The patients have to accept to continue same dose until end of the last assessment
Medical clearance to participate
Exclusion Criteria:
Having established contracture of the knee/hip joint
Aged over 65 years
History of surgery for knee/hip disorders
Non-traumatic etiology
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block
We'll reach out to this number within 24 hrs